Filipovich, A.H., Weisdorf, D., Pavletic, S., et al. (2005) National Institutes of Health Development Project on Criteria for Clinical Trials in Chronic Graft Versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biology of Blood and Marrow Transplantation, 11, 945-956.
http://dx.doi.org/10.1016/j.bbmt.2005.09.004

has been cited by the following article:

• TITLE: Ocular Graft versus Host Disease: A Review of Clinical Manifestations, Diagnostic Approaches and Treatment

  AUTHORS: Sridevi Nair, Murugesan Vanathi, Anita Ganger, Radhika Tandon

  KEYWORDS: Stem Cell Transplantation, Ocular, Graft Host Disease

  JOURNAL NAME: Open Journal of Ophthalmology, Vol.6 No.1, February 16, 2016

  ABSTRACT: Allogenic haematological stem cell transplantation (allo-SCT) from a human leukocyte antigen (HLA) matched related or unrelated donor is used as a curative therapy for a large number of malignant and non-malignant haematological diseases. The curative effect of allo-SCT is achieved by graft versus leukaemia effect while the downside of the graft versus patient activity is the graft-versus-host-disease (GVHD), a major reason for mortality and morbidity. The search of articles for this review had been accomplished using Ovid, Medline, Embase, Pubmed and was supplemented by retrieving cross references also. Electronic literature search for English language articles with full text access was performed using graft versus host disease, ocular, management, dry eyes as key words. This review has been intended to explicate the classification, pathogenesis, risk factors and management of ocular graft versus host disease.